TY - JOUR
T1 - Nano-Engineering Strategies for Tumor-Specific Therapy
AU - Li, Zijin
AU - Xie, Hai Yan
AU - Nie., Weidong
N1 - Publisher Copyright:
© 2024 Wiley-VCH GmbH.
PY - 2024/5/17
Y1 - 2024/5/17
N2 - Nanodelivery systems (NDSs) provide promising prospects for decreasing drug doses, reducing side effects, and improving therapeutic effects. However, the bioapplications of NDSs are still compromised by their fast clearance, indiscriminate biodistribution, and limited tumor accumulation. Hence, engineering modification of NDSs aiming at promoting tumor-specific therapy and avoiding systemic toxicity is usually needed. An NDS integrating various functionalities, including flexible camouflage, specific biorecognition, and sensitive stimuli-responsiveness, into one sequence would be “smart” and highly effective. Herein, we systematically summarize the related principles, methods, and progress. At the end of the review, we predict the obstacles to precise nanoengineering and prospects for the future application of NDSs.
AB - Nanodelivery systems (NDSs) provide promising prospects for decreasing drug doses, reducing side effects, and improving therapeutic effects. However, the bioapplications of NDSs are still compromised by their fast clearance, indiscriminate biodistribution, and limited tumor accumulation. Hence, engineering modification of NDSs aiming at promoting tumor-specific therapy and avoiding systemic toxicity is usually needed. An NDS integrating various functionalities, including flexible camouflage, specific biorecognition, and sensitive stimuli-responsiveness, into one sequence would be “smart” and highly effective. Herein, we systematically summarize the related principles, methods, and progress. At the end of the review, we predict the obstacles to precise nanoengineering and prospects for the future application of NDSs.
KW - bioinspired
KW - nanodelivery systems
KW - stimuli-responsive
KW - tumor targeting
UR - http://www.scopus.com/inward/record.url?scp=85186446779&partnerID=8YFLogxK
U2 - 10.1002/cmdc.202300647
DO - 10.1002/cmdc.202300647
M3 - Review article
C2 - 38356248
AN - SCOPUS:85186446779
SN - 1860-7179
VL - 19
JO - ChemMedChem
JF - ChemMedChem
IS - 10
M1 - e202300647
ER -